| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/21/2008 | CA2658725A1 Using pi3k and mek modulators in treatments of cancer |
| 02/21/2008 | CA2658557A1 Optimized antibodies that target cd19 |
| 02/21/2008 | CA2658050A1 Diagnosis and treatment of cancer using anti-desmoglein 3 antibodies |
| 02/21/2008 | CA2650206A1 Novel crystal of 5-aminolevulinic acid phosphate and process for producing the same |
| 02/21/2008 | CA2633112A1 A method of treating tumors with azaxanthones |
| 02/20/2008 | EP1890151A1 Oncolytic viruses as phenotyping agents for neoplasms |
| 02/20/2008 | EP1889915A1 APO-2 ligand |
| 02/20/2008 | EP1889911A2 An antisense oligonucleotide preparation method |
| 02/20/2008 | EP1889836A1 Novel pyridine derivative and pyrimidine derivative (3) |
| 02/20/2008 | EP1889639A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents |
| 02/20/2008 | EP1889631A1 Cell growth inhibition |
| 02/20/2008 | EP1889630A1 Vaccines |
| 02/20/2008 | EP1889624A2 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites |
| 02/20/2008 | EP1889617A1 Triphenyl modified 5-membered heterocycles and their use as anticancer and antiflammatory agents |
| 02/20/2008 | EP1889609A2 Immune response modifier foam formulations |
| 02/20/2008 | EP1888648A2 Methods of treating, diagnosing or detecting cancer |
| 02/20/2008 | EP1888647A2 Generation and profiling of fully human hucal gold®-derived therapeutic antibodies specific for human cd38 |
| 02/20/2008 | EP1888619A2 Compounds modifying apoptosis |
| 02/20/2008 | EP1888593A2 Thienopyridines |
| 02/20/2008 | EP1888590A2 Crystalline forms of a pyrrolotriazine compound |
| 02/20/2008 | EP1888588A2 Protein kinase inhibitors |
| 02/20/2008 | EP1888587A1 2-amido-6-amino-8-oxopurine derivatives as toll-like receptor modulators for the treatment of cancer and viral infections, such as hepatitis c |
| 02/20/2008 | EP1888584A1 1, 6 -dihydro- 1,3, 5, 6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same as inhibitors of ikk enzyme activity |
| 02/20/2008 | EP1888578A2 Imidazoquinolines as lipid kinase inhibitors |
| 02/20/2008 | EP1888572A1 Quinazolines and their use as aurora kinase inhibitors |
| 02/20/2008 | EP1888561A1 Pyrazolyl-amino- substituted pyrimidines and their use in the treatment of cancer |
| 02/20/2008 | EP1888550A2 Apoptosis promoters |
| 02/20/2008 | EP1888543A1 Apoptosis promoters |
| 02/20/2008 | EP1888122A2 A method for preparing a stable immunogenic product comprising antigenic heterocomplexes of tnf alpha and a carrier protein |
| 02/20/2008 | EP1888121A2 Anticancer targeted conjugates comprising a succinyl or glutaryl linker |
| 02/20/2008 | EP1888120A2 Novel salts of conjugated psychotropic drugs and processes of preparing same |
| 02/20/2008 | EP1888116A2 Use of fumagillin and the derivatives thereof to increase the bioavailability of the macrocyclic lactones |
| 02/20/2008 | EP1888114A2 Anti- mcp-1 antibodies, compositions, methods and uses |
| 02/20/2008 | EP1888113A2 Tweak binding antibodies |
| 02/20/2008 | EP1888112A2 Psk-1 and its modulators for the treatment/diagnosis of cancer |
| 02/20/2008 | EP1888106A2 Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
| 02/20/2008 | EP1888097A1 Fk 228 derivates as hdac inhibitors |
| 02/20/2008 | EP1888093A2 Botanical anticancer formulations |
| 02/20/2008 | EP1888087A1 Ethanolic extract of animal origin combined with enzymes acts therapeutically on malignant and other diseases. |
| 02/20/2008 | EP1888078A2 Sulphone derivatives for treatment of cancer |
| 02/20/2008 | EP1888073A1 Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl]and salts thereof |
| 02/20/2008 | EP1888072A1 Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl]and salts thereof |
| 02/20/2008 | EP1888069A2 New antiproliferative drug |
| 02/20/2008 | EP1888067A1 Combination therapy comprising a diaryl urea compound and a pi3, akt kinase or mtor inhibitors (rapamycins) for cancer treatment |
| 02/20/2008 | EP1888065A2 Combination therapy comprising diaryl ureas for treating diseases |
| 02/20/2008 | EP1888061A1 Nutrient composition for treating sarcoma and prostate cancer |
| 02/20/2008 | EP1888051A2 Sulphonamido-substituted cyclohexyl sulphones for treatment of cancer |
| 02/20/2008 | EP1888050A2 Cyclohexyl sulphones for treatment of cancer |
| 02/20/2008 | EP1622620B1 Quinazoline derivatives and their use in the treatment of cancer |
| 02/20/2008 | EP1560829B1 Pyrimido compounds having antiproliferative activity (ii) |
| 02/20/2008 | EP1556384B1 Pyrimido compounds having antiproliferative activity |
| 02/20/2008 | EP1539108B1 Vesicle-encapsulated corticosteroids for the treatment of cancer |
| 02/20/2008 | EP1496908B1 Combination of glivec(sti571) with a cyclin-dependent kinase inhibitor, especially flavopiridol in the treatment of cancer |
| 02/20/2008 | EP1432417B1 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 02/20/2008 | EP1414828B9 Antitumoral analogs |
| 02/20/2008 | EP1406667B1 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
| 02/20/2008 | EP1347769A4 Cancer preventative effect of morinda citrifolia |
| 02/20/2008 | EP1326638B9 Vaccines against cancers |
| 02/20/2008 | EP1289548B1 Immune system stimulating means |
| 02/20/2008 | EP1175411B1 Cyclothiocarbamate derivatives as progesterone receptor modulators |
| 02/20/2008 | EP1112497B1 Ykl-40 as a marker and prognostic indicator for cancers and detection of infections |
| 02/20/2008 | EP1072272B1 Method for producing a specific antiserum against the universal tumorous antigen and method for diagnosing malignant tumours using said antiserum |
| 02/20/2008 | EP1007672B1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptic cell death pathways |
| 02/20/2008 | EP0918872B1 A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis |
| 02/20/2008 | EP0837687B1 Hapten modified tumor cell extract and methods of treating cancer |
| 02/20/2008 | EP0689551B1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 02/20/2008 | CN101128484A Compositions and methods relating to anti IGF-1 receptor antibodies |
| 02/20/2008 | CN101128461A Imidazo (1, 2-a) pyridine compounds as VEGF-R2 inhibitors |
| 02/20/2008 | CN101128456A Quinazoline derivatives as tyrosine kinase inhibitors |
| 02/20/2008 | CN101128454A Pyridine carboxamide derivatives for use as anticancer agents |
| 02/20/2008 | CN101128425A Dimeric IAP inhibitors |
| 02/20/2008 | CN101128202A Farnesyl protein transferase inhibitors and methods for treating proliferative diseases |
| 02/20/2008 | CN101128195A Bicalutamide for sending increased steady state blood plasma level |
| 02/20/2008 | CN101126102A Marine actinomycetes for generating antineoplastic compound Norharmane |
| 02/20/2008 | CN101125891A TAT-PEIII fusion protein used for tumor partial interventional therapy and preparation method thereof |
| 02/20/2008 | CN101125888A Expression production for recombination immunoglobulin capable of specifically identifying blood vessel endothelial cell growth factor and application thereof |
| 02/20/2008 | CN101125865A Chiral ruthenium complex and application of the same used as antineoplastic |
| 02/20/2008 | CN101125855A Method for separating hemporfin isomer and separated isomer |
| 02/20/2008 | CN101125850A Andrographolide derivatives and application of the same in pharmacy |
| 02/20/2008 | CN101125842A Separation and identification for novel flavonoid compounds in bruguiera gymnoihiza and antineoplastic use thereof |
| 02/20/2008 | CN101125837A C-glycosides type slycolipid compounds and use thereof |
| 02/20/2008 | CN101125836A Costene lactone derivative and medical use thereof |
| 02/20/2008 | CN101125203A Sonosensitizer with oxygen-carrying function |
| 02/20/2008 | CN101125178A Traditional Chinese medicine for treating tumor |
| 02/20/2008 | CN101125175A Fritillaria thunergii medicine composition for treating acute leukemia and its new use |
| 02/20/2008 | CN101125163A Plant extract and preparation with antitumor efficacy |
| 02/20/2008 | CN101125151A Bacteroides signal molecule microecological preparation and its preparation method |
| 02/20/2008 | CN101125150A Application of nanometer zinc oxide in preparing medicine for treating malignant tumor |
| 02/20/2008 | CN101125146A Medicine target for preventing and treating cardiovascular and cerebrovascular diseases associated with inflammation and its inhibitor |
| 02/20/2008 | CN101125142A Application of artemisine in preparing artitumor multi-medicine-resistant medicine |
| 02/20/2008 | CN101125141A Anticancer medicine composition and its application in preparing anticancer medicine |
| 02/20/2008 | CN101125140A Application of dihydroartemisinin in reinforcing chemotherapy medicine antitumor curative effect |
| 02/20/2008 | CN101125127A Artemisinin derivatives freeze-dried preparation and preparation method |
| 02/20/2008 | CN101125016A Method for producing high selenium and germanium beverage |
| 02/20/2008 | CN100370025C Small interference RNA inhibiting the expression of 1A6/DRIM gene and its action site |
| 02/20/2008 | CN100369936C Sulfonated changium root polysaccharides and preparing method and use thereof |
| 02/20/2008 | CN100369934C Monoclonal antibody against human 4-1BBL and its use |
| 02/20/2008 | CN100369931C Monoclonal antibody against human B7-1 molecule and its use |
| 02/20/2008 | CN100369919C Tricyclic protein kinase inhibitors |
| 02/20/2008 | CN100369917C Himbacine analogues as thrombin receptor antagonists |